You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Follow Hugh Langley Every time Hugh publishes a story, you’ll get an alert straight to your inbox!

More than 1,300 oncology drugs are in the development pipeline, waiting to potentially embark on the long journey toward their commercial debut. This journey is usually an arduous one, made even more ...

Verily has rapidly ramped up its work in healthcare and research in the past two years with new initiatives and new hires. Leveraging its technology capabilities, Verily, a subsidiary of Alphabet and ...

Alphabet’s life sciences arm Verily has paused one of its first research projects — contact lenses that aim to measure a diabetic patient’s glucose levels. Brian Otis, PhD, chief technical officer of ...

Alphabet’s life science subsidiary Verily is working to detach itself from Google’s technology and possibly move outside its parent company, according to reporting by Insider. The plan, internally ...

Verily will lay off about 15% of its staff as part of a restructuring that will see Google’s life-science-focused sister company slim down its portfolio of disparate health projects and largely exit ...

Alphabet's life science offshoot Verily announced it had raised $1 billion in an investment round led by its parent company alongside a shakeup of its executive team. The company's founder Andy Conrad ...

Verily, Alphabet’s life sciences group, is investing big in developing technologies for the millions of people worldwide with diabetes. Verily announced today that it is teaming up with pharmaceutical ...

For Alphabet’s Verily, O is for OneOncology. The two companies have partnered up to accelerate cancer clinical trials. OneOncology, which brings together independent oncology practices, will integrate ...

It’s a make-or-break moment for Verily, as the sprawling Google offshoot rapidly accelerates its strategy to take its most promising products and turn them into tools that not only transform medicine, ...

The Alphabet-owned healthcare unit Verily is laying off more than 200 staff, about 15% of the workforce. The cuts were announced in a memo to staff sent on Wednesday. CEO Stephen Gillett said the ...

The Verily website is displayed on a laptop computer in an arranged photograph taken in Arlington, Virginia, U.S., on Thursday, May 7, 2020. Verily, the life sciences unit owned by Alphabet Inc., has ...